CYRX
CYRX
NASDAQ · Life Sciences Tools & Services

Cryoport Inc

$15.49
-0.37 (-2.33%)
As of Jul 4, 10:27 PM ET ·
Financial Highlights (FY 2026)
Revenue
177.34M
Net Income
78.82M
Gross Margin
47.1%
Profit Margin
44.4%
Rev Growth
-9.5%
D/E Ratio
0.37
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 47.1% 47.1% 39.0% 39.0%
Operating Margin -20.9% -18.8% 22.9% 18.0%
Profit Margin 44.4% 42.2% 14.0% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 177.34M 195.85M 137.31M 144.41M
Gross Profit 83.60M 92.32M 53.62M 56.39M
Operating Income -37,046,436 -36,821,416 31.39M 25.95M
Net Income 78.82M 78.34M 19.23M 25.18M
Gross Margin 47.1% 47.1% 39.0% 39.0%
Operating Margin -20.9% -18.8% 22.9% 18.0%
Profit Margin 44.4% 42.2% 14.0% 17.4%
Rev Growth -9.5% -9.5% +13.1% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 106.05M 106.05M 221.73M 216.61M
Total Equity 284.32M 284.32M 262.41M 301.43M
D/E Ratio 0.37 0.37 0.84 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,153,059 -9,602,878 43.82M 47.91M
Free Cash Flow 11.97M 10.29M